We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Launches PRIME Initiative to Speed Priority Medicines to Market
EMA Launches PRIME Initiative to Speed Priority Medicines to Market
The European Medicines Agency has launched its PRIority MEdicines initiative to accelerate breakthrough therapies that offer a major therapeutic advantage over existing treatments.